NIKA PHARMACEUTICALS, INC — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Savov Dimitar Slavchev | CEO, CFO, President | Sale | 2,000,000 | $0.25 | $500,000 | 455,589,500 | Mar 18, 2025 |
| NIKA PHARMACEUTICALS, INC | President, CEO, CFO | Sale | 6,300,000 | $0.01 | $63,000 | — | Sep 12, 2022 |
| NIKA PHARMACEUTICALS, INC | Secretary | Other | 5,000,000 | $50,000.00 | $250,000,000,000 | 5,000,000 | Jul 20, 2022 |